Arnold Monto to Influenza, Human
This is a "connection" page, showing publications Arnold Monto has written about Influenza, Human.
Connection Strength
2.453
-
Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses. J Infect Dis. 2021 07 02; 224(1):49-59.
Score: 0.157
-
Effectiveness of the Live Attenuated Influenza Vaccine: Was the Addition of the Second Type B Lineage a Step Too Far? Clin Infect Dis. 2020 06 10; 70(12):2514-2516.
Score: 0.146
-
Improving Influenza Vaccine Effectiveness: Ways to Begin Solving the Problem. Clin Infect Dis. 2019 10 30; 69(10):1824-1826.
Score: 0.140
-
Neuraminidase, the Forgotten Surface Antigen, Emerges as an Influenza Vaccine Target for Broadened Protection. J Infect Dis. 2019 04 08; 219(Suppl_1):S75-S80.
Score: 0.134
-
Efficacy and Safety of Oseltamivir in Children: Systematic Review and Individual Patient Data Meta-analysis of Randomized Controlled Trials. Clin Infect Dis. 2018 05 02; 66(10):1492-1500.
Score: 0.126
-
Reflections on The Global Influenza Surveillance and Response System (GISRS) at 65 Years: An Expanding Framework for Influenza Detection, Prevention and Control. Influenza Other Respir Viruses. 2018 01; 12(1):10-12.
Score: 0.123
-
Application of an Individual-Based Transmission Hazard Model for Estimation of Influenza Vaccine Effectiveness in a Household Cohort. Am J Epidemiol. 2017 Dec 15; 186(12):1380-1388.
Score: 0.123
-
Maximum likelihood estimation of influenza vaccine effectiveness against transmission from the household and from the community. Stat Med. 2018 03 15; 37(6):970-982.
Score: 0.122
-
The risk of lower respiratory tract infection following influenza virus infection: A systematic and narrative review. Vaccine. 2018 01 02; 36(1):141-147.
Score: 0.122
-
The Household Influenza Vaccine Effectiveness Study: Lack of Antibody Response and Protection Following Receipt of 2014-2015 Influenza Vaccine. Clin Infect Dis. 2017 Oct 30; 65(10):1644-1651.
Score: 0.122
-
The Doctrine of Original Antigenic Sin: Separating Good From Evil. J Infect Dis. 2017 06 15; 215(12):1782-1788.
Score: 0.119
-
Untangling the Effects of Prior Vaccination on Subsequent Influenza Vaccine Effectiveness. J Infect Dis. 2017 03 15; 215(6):841-843.
Score: 0.117
-
Moving Toward Improved Influenza Vaccines. J Infect Dis. 2017 02 15; 215(4):500-502.
Score: 0.116
-
Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection. J Infect Dis. 2011 Dec 15; 204(12):1879-85.
Score: 0.080
-
Coronavirus disease 2019 (COVID-19) Versus Influenza in Hospitalized Adult Patients in the United States: Differences in Demographic and Severity Indicators. Clin Infect Dis. 2021 12 16; 73(12):2240-2247.
Score: 0.041
-
Influenza and COVID-19: What does co-existence mean? Influenza Other Respir Viruses. 2021 05; 15(3):407-412.
Score: 0.037
-
Home collection of nasal swabs for detection of influenza in the Household Influenza Vaccine Evaluation Study. Influenza Other Respir Viruses. 2021 03; 15(2):227-234.
Score: 0.037
-
Preventing influenza in healthy adults: the evolving story. JAMA. 2000 Oct 04; 284(13):1699-701.
Score: 0.037
-
Influenza Vaccine Effectiveness Against Hospitalization in Fully and Partially Vaccinated Children in Israel: 2015-2016, 2016-2017, and 2017-2018. Clin Infect Dis. 2019 11 27; 69(12):2153-2161.
Score: 0.035
-
Prevention of Influenza Hospitalization Among Adults in the United States, 2015-2016: Results From the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN). J Infect Dis. 2019 09 13; 220(8):1265-1275.
Score: 0.035
-
Study of Healthcare Personnel with Influenza and other Respiratory Viruses in Israel (SHIRI): study protocol. BMC Infect Dis. 2018 Nov 06; 18(1):550.
Score: 0.033
-
Sera from Individuals with Narrowly Focused Influenza Virus Antibodies Rapidly Select Viral Escape Mutations In Ovo. J Virol. 2018 10 01; 92(19).
Score: 0.032
-
Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States. J Infect Dis. 2018 06 20; 218(2):189-196.
Score: 0.032
-
Severe morbidity among hospitalised adults with acute influenza and other respiratory infections: 2014-2015 and 2015-2016. Epidemiol Infect. 2018 08; 146(11):1350-1358.
Score: 0.032
-
Stochastic processes constrain the within and between host evolution of influenza virus. Elife. 2018 05 03; 7.
Score: 0.032
-
Influenza Antiviral Prescribing for Outpatients With an Acute Respiratory Illness and at High Risk for Influenza-Associated Complications During 5 Influenza Seasons-United States, 2011-2016. Clin Infect Dis. 2018 03 19; 66(7):1035-1041.
Score: 0.031
-
Influenza vaccine effectiveness in older adults compared with younger adults over five seasons. Vaccine. 2018 02 28; 36(10):1272-1278.
Score: 0.031
-
Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018. MMWR Morb Mortal Wkly Rep. 2018 Feb 16; 67(6):180-185.
Score: 0.031
-
Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season. N Engl J Med. 2017 08 10; 377(6):534-543.
Score: 0.030
-
Prospects for pandemic influenza control with currently available vaccines and antivirals. J Infect Dis. 1997 Aug; 176 Suppl 1:S32-7.
Score: 0.030
-
Prior-Season Vaccination and Risk of Influenza During the 2014-2015 Season in the United States. J Infect Dis. 2017 07 15; 216(2):284-285.
Score: 0.030
-
Report of the WHO technical consultation on the effect of maternal influenza and influenza vaccination on the developing fetus: Montreal, Canada, September 30-October 1, 2015. Vaccine. 2017 04 25; 35(18):2279-2287.
Score: 0.029
-
Interim Estimates of 2016-17 Seasonal Influenza Vaccine Effectiveness - United States, February 2017. MMWR Morb Mortal Wkly Rep. 2017 Feb 17; 66(6):167-171.
Score: 0.029
-
Vaccination has minimal impact on the intrahost diversity of H3N2 influenza viruses. PLoS Pathog. 2017 01; 13(1):e1006194.
Score: 0.029
-
Nonpharmaceutical influenza mitigation strategies, US communities, 1918-1920 pandemic. Emerg Infect Dis. 2006 Dec; 12(12):1961-4.
Score: 0.014
-
Simulation studies of influenza epidemics: assessment of parameter estimation and sensitivity. Int J Epidemiol. 1984 Dec; 13(4):496-501.
Score: 0.012
-
HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy. BMC Infect Dis. 2019 May 22; 19(1):453.
Score: 0.008
-
Comparison of a frailty short interview to a validated frailty index in adults hospitalized for acute respiratory illness. Vaccine. 2019 06 27; 37(29):3849-3855.
Score: 0.008
-
Interrupting the transmission of respiratory tract infections: theory and practice. Clin Infect Dis. 1999 Feb; 28(2):200-4.
Score: 0.008
-
The Tecumseh study of respiratory illness. VIII. Acute infection in chronic respiratory disease and comparison groups. Am Rev Respir Dis. 1975 Jan; 111(1):27-36.
Score: 0.002